Lea Eslava-Kim, PharmD

Drug Information Specialist https://www.clinicalpainadvisor.com

Lea Eslava-Kim, PharmD, is a Drug Information Specialist for MPR. She received her doctorate in pharmacy from the Ernest Mario School of Pharmacy, Rutgers University and completed her pharmacy residency at Clara Maass Medical Center. She is a licensed pharmacist.

All articles by Lea Eslava-Kim, PharmD

news

First-in-Class Opioid Analgesic Results for Chronic Back Pain

Nektar Therapeutics announced positive results from the SUMMIT-07 Phase 3 study of NKTR-181 for the treatment of moderate-to-severe chronic pain.

Lea Eslava-Kim, PharmD

March 29, 2017

news

FDA Approves Zilretta NDA for Knee Osteoarthritis

The Food and Drug Administration has accepted for review the New Drug Application for Zilretta for the treatment of patients with osteoarthritis of the knee.

Lea Eslava-Kim, PharmD

February 16, 2017